Page last updated: 2024-11-05

trimellitic anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trimellitic anhydride (TMA) is a white solid organic compound with the formula C9H4O5. It is a cyclic anhydride derived from trimellitic acid. TMA is an important industrial chemical used in the production of various polymers, including unsaturated polyester resins, alkyd resins, and polyimide resins. Its synthesis typically involves the oxidation of 1,2,4-trimethylbenzene or other aromatic compounds. TMA is a versatile intermediate due to its three reactive anhydride groups, which can undergo various reactions, such as hydrolysis, esterification, and ring-opening polymerization. Its importance stems from its ability to impart desirable properties to polymers, such as high heat resistance, excellent electrical insulation, and good mechanical strength. The study of TMA focuses on its reactivity, synthesis optimization, and applications in various industries, including aerospace, automotive, and electronics. TMA is also investigated for its potential applications in renewable energy technologies, such as solar cells and batteries.'

trimellitic anhydride: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trimellitic anhydride : A 2-benzofuran compound having oxo groups at the 1- and 3-positions and a carboxy substituent at the 5-position; the cyclic anhydride formed from the carboxy groups at the 1- and 2-positions of trimellitic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11089
CHEMBL ID2137687
CHEBI ID53050
SCHEMBL ID22458
MeSH IDM0064919

Synonyms (111)

Synonym
AC-811
1,2,4-benzenetricarboxylic anhydride
ec 209-008-0
5-18-08-00562 (beilstein handbook reference)
80t61euu7h ,
unii-80t61euu7h
1,2,4-benzenetricarboxylic anhydride treated hemoglobin
trimellitic anhydride treated bsa
trimellitic anhydride treated igg
trimellitic anhydride treated casein
trimellitic anhydride-dendrimers
trimellitic anhydride treated hemoglobin
5-isobenzofurancarboxylic acid, 1,3-dihydro-1,3-dioxo-
1,3-dioxoisobenzofuran-5-carboxylic acid
trimellitic anhydride-trypsin treated bsa
trimellitic anhydride treated hsa
trimellitic anhydride treated .beta.-lactoglobulin from bovine whey
1,2,4-benzenetricarboxylic anhydride treated .beta.-lactoglobulin from bovine whey
1,3-dioxo-1,3-dihydro-isobenzofuran-5-carboxylic acid
trimellitic anhydride treated human transferrin
1,3-dioxo-1,3-dihydro-2-benzofuran-5-carboxylic acid
1,4-benzenetricarboxylic acid anhydride
trimellitic acid 1,2-anhydride
anhydrotrimellic acid
1,4-benzenetricarboxylic acid 1,2-anhydride
nsc60252
trimellitic acid anhydride
wln: t56 bvovj gvq
tman
nsc-60252
anhydrotrimellitic acid
5-phthalanacarboxylic acid,3-dioxo-
trimellic acid 1,2-anhydride
1,4-benzenetricarboxylic acid, cyclic 1,2-anhydride
552-30-7
trimellitic acid,2-anhydride
nci-c56633
4-carboxyphthalic anhydride
1,3-dioxo-5-phthalancarboxylic acid
5-isobenzofurancarboxylic acid,3-dihydro-1,3-dioxo-
trimellic acid anhydride
1,4-benzenetricarboxylic anhydride
1,3-dioxo-5-isobenzofurancarboxylic acid
5-phthalanacarboxylic acid, 1,3-dioxo-
1,2,4-benzenetricarboxylic acid 1,2-anhydride
1,2,4-benzenetricarboxylic acid anhydride
hsdb 4299
ccris 6282
1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid
einecs 209-008-0
1,2,4-benzenetricarboxylic acid, cyclic 1,2-anhydride
brn 0009394
epon 9150
trimellitic acid cyclic 1,2-anhydride
nsc 60252
benzene-1,2,4-tricarboxylic acid 1,2-anhydride
1,2,4-benzenetricarboxylic anhydride, 97%
NCGC00164022-01
trimellitic anhydride
inchi=1/c9h4o5/c10-7(11)4-1-2-5-6(3-4)9(13)14-8(5)12/h1-3h,(h,10,11
CHEBI:53050 ,
benzene-1,2,4-tricarboxylic-1,2-anhydride
C0959
1,2,4-benzenetricarboxylic 1,2-anhydride
1,3-dioxo-2-benzofuran-5-carboxylic acid
AKOS000120069
NCGC00164022-02
dtxcid906235
cas-552-30-7
dtxsid7026235 ,
tox21_303117
NCGC00256953-01
NCGC00259615-01
tox21_202066
1,3-dioxoisobenzofuran-5-carboxylic acid;trimellitic anhydride
A830542
BBL010496
c9h4o5
1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylic acid
FT-0689091
STL146149
EPITOPE ID:113235
cyclic 1,2-anhydride
SCHEMBL22458
1,2,4 benzenetricarboxylic acid anhydride
benzene-1,2,4-tricarboxylic anhydride
1,2,4 benzenetricarboxylic anhydride
1,2,4-benzene tricarboxylic anhydride
CHEMBL2137687
trimellitic anhydride [inci]
trimellitic anhydride [mi]
trimellitic anhydride [hsdb]
1,2,4-benzenetricarboxylicanhydride
1,2,4-benzenetricarboxylic acid anhydride-1,2
1,3-dioxo-1,3-dihydro-isobenzofuran-5-carboxylic acid #
trimellic acid-1,2-anhydride
W-105576
benzene-1,2,4-tricarboxylic acidanhydride
trimellitic anhydride, purum, >=97.0% (t)
mfcd00005925
BP-13468
F0001-1448
CS-W015822
SY001151
VS-02531
Q1675143
AC8872
1,2,4-benzenetricarboxylic anhydride trimellitic anhydride tma
benzene-1,2,4-tricarboxylicacidanhydride
EN300-18016
Z57127496

Research Excerpts

Overview

Trimellitic anhydride (TMA) is a chemical agent classified as a low molecular weight (LMW) agent causing occupational rhinitis (OR) or asthma. Trimilite is a low-molecular-weight, reactive chemical used in the manufacture of plastics.

ExcerptReferenceRelevance
"Trimellitic anhydride (TMA) is a chemical agent classified as a low molecular weight (LMW) agent causing occupational rhinitis (OR) or asthma. "( Trimellitic anhydride facilitates transepithelial permeability disrupting tight junctions in sinonasal epithelial cells.
Cooksley, C; Fujieda, S; Javadiyan, S; Liu, S; Ogi, K; Psaltis, AJ; Ramezanpour, M; Vreugde, S; Wormald, PJ, 2021
)
3.51
"Trimellitic anhydride (TMA) is a low-molecular-weight chemical known to cause occupational asthma. "( Respiratory hypersensitivity to trimellitic anhydride in Brown Norway rats: analysis of dose-response following topical induction and time course following repeated inhalation challenge.
Pauluhn, J, 2003
)
2.05
"Trimellitic anhydride (TMA) is a cause of asthma in man. "( Airway responses in Brown Norway rats following inhalation sensitization and challenge with trimellitic anhydride.
Andrew, ME; Hubbs, AF; Siegel, PD; Zhang, XD, 2006
)
2
"Trimellitic anhydride is a low-molecular-weight, reactive chemical used in the manufacture of plastics."( Syndromes in workers exposed to trimellitic anhydride. A longitudinal clinical and immunologic study.
Chacon, R; Levitz, D; Patterson, R; Prunzansky, JJ; Tuntland, PA; Wolkonsky, P; Zeiss, CR, 1983
)
1.27
"Trimellitic anhydride is a cause of occupational asthma in humans. "( Neurogenic goblet cell secretion and bronchoconstriction in guinea pigs sensitised to trimellitic anhydride.
Barnes, PJ; Chung, KF; Hayes, JP; Kuo, HP; Newman Taylor, AJ; Rogers, DF; Rohde, JA, 1995
)
1.96
"Trimellitic anhydride (TMA) is a small molecular weight industrial compound that will cause asthma-like symptoms in humans. "( Trimellitic anhydride-induced allergic response in the lung: role of the complement system in cellular changes.
Arndt, ML; Fraser, DG; Regal, JF, 1995
)
3.18
"Trimellitic anhydride (TMA) is a low molecular weight chemical which can cause occupational asthma. "( Role of eicosanoids in airflow obstruction and airway plasma exudation induced by trimellitic anhydride-conjugate in guinea-pigs 3 and 8 weeks after sensitization.
Arakawa, H; Kawikova, I; Lindén, A; Löfdahl, CG; Lötvall, J; Skoogh, BE, 1994
)
1.96
"Trimellitic anhydride (TMA) is a low molecular weight chemical that may cause occupational asthma in human beings. "( Airway allergy to trimellitic anhydride in guinea pigs: different time courses of IgG1 titer and airway responses to allergen challenge.
Arakawa, H; Hayes, J; Kawikova, I; Löfdahl, CG; Lötvall, J; Skoogh, BE; Taylor, AJ; Tee, R, 1993
)
2.06
"Trimellitic anhydride (TMA) is a low-molecular-weight compound which causes occupational allergy. "( Inflammatory responses in skin and airways after allergen challenge in brown Norway rats sensitized to trimellitic anhydride.
Andius, P; Arakawa, H; Lötvall, J; Mölne, J; Pullerits, T; Skoogh, BE, 1996
)
1.95
"Trimellitic anhydride (TMA) is a low-molecular-weight compound capable of inducing occupational asthma in man. "( Development of antigen-specific IgE after sensitisation with trimellitic anhydride in rats is attenuated by glucocorticoids and cyclosporin A.
Dahlgren, U; Lötvall, J; Pullerits, T; Skoogh, BE, 1997
)
1.98
"Trimellitic anhydride (TMA) is a small molecular weight chemical used in the paint and plastics industry that can cause asthma-like symptoms in humans. "( The role of IgG1 and IgG2 in trimellitic anhydride-induced allergic response in the guinea pig lung.
Fraser, DG; Graziano, FM; Larsen, CP; Regal, JF, 1998
)
2.03
"Trimellitic anhydride (TMA) is a low-molecular-weight chemical known to cause occupational asthma. "( Trimellitic anhydride-induced eosinophilia in a mouse model of occupational asthma.
Mohrman, ME; Regal, JF; Sailstad, DM, 2001
)
3.2
"Trimellitic anhydride (TMA) is a chemical intermediate that has been shown to cause immunologically mediated respiratory syndromes in humans. "( Evidence of immunologic control of lung injury induced by trimellitic anhydride.
Garvin, PJ; Hatoum, NS; Leach, CL; Ratajczak, HV; Zeiss, CR, 1988
)
1.96
"Trimellitic anhydride (TMA) is a chemical intermediate used in the paint and plastics industry. "( The pathologic and immunologic response to inhaled trimellitic anhydride in rats.
Garvin, PJ; Hatoum, NS; Leach, CL; Ratajczak, HV; Roger, JC; Zeiss, CR, 1987
)
1.97
"Trimellitic anhydride (TMA) is an industrial chemical used as a plasticizer (and serves as a model of occupational immunologic lung disease)."( Responses of human airways to inhaled chemicals.
Harris, KE; Patterson, R, 1985
)
0.99

Effects

ExcerptReferenceRelevance
"Trimellitic anhydride has widespread usage in a variety of industrial processes. "( Simultaneous determination of trimellitic anhydride and its trimellitic acid impurity by GC/FID.
Althaus, JR; Rushing, LG; Thompson, HC,
)
1.86

Actions

Trimellitic anhydride (TMA) is a cause of occupational asthma in humans.

ExcerptReferenceRelevance
"Trimellitic anhydride (TMA) is a cause of asthma in man. "( Airway responses in Brown Norway rats following inhalation sensitization and challenge with trimellitic anhydride.
Andrew, ME; Hubbs, AF; Siegel, PD; Zhang, XD, 2006
)
2
"Trimellitic anhydride is a cause of occupational asthma in humans. "( Neurogenic goblet cell secretion and bronchoconstriction in guinea pigs sensitised to trimellitic anhydride.
Barnes, PJ; Chung, KF; Hayes, JP; Kuo, HP; Newman Taylor, AJ; Rogers, DF; Rohde, JA, 1995
)
1.96

Toxicity

ExcerptReferenceRelevance
" However, the cause of the pulmonary and hematologic damage remains uncertain and may represent either immunologic or direct toxic effects of TMA."( Trimellitic anhydride Toxicity. A cause of acute multisystem failure.
Byron, GE; Franco, M; Greenberg, SD; Nicotra, MB; Patterson, R; Rivera, M; Yawn, DH; Zeiss, CR, 1981
)
1.71
" The Panel concluded that Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer and Phthalic Anhydride/Trimellitic Anhydride/Glycols Copolymer are safe in nail product formulations in the present practices of use and concentration, but the data are insufficient to make a determination of safety on the use of these 2 ingredients in all other types of cosmetic formulations."( Safety Assessment of Trimellitic Anhydride Copolymers as Used in Cosmetics.
Belsito, DV; Bergfeld, WF; Fiume, MM; Gill, LJ; Heldreth, B; Hill, RA; Klaassen, CD; Liebler, DC; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.7

Compound-Compound Interactions

ExcerptReferenceRelevance
"This study was to determine the anti-inflammatory effect of thermal therapy combined with LED irradiation on trimellitic anhydride (TMA)-induced acute contact hypersensitivity (CHS) mouse model."( Effects of thermal therapy combined with blue light-emitting diode irradiation on trimellitic anhydride-induced acute contact hypersensitivity mouse model.
Chai, OH; Fan, YJ; Jeong, HJ; Nguyen, TV; Piao, CH; Song, CH, 2022
)
1.16
"These results indicate that thermal therapy combined with LED irradiation alleviated TMA-induced acute CHS in the mouse model."( Effects of thermal therapy combined with blue light-emitting diode irradiation on trimellitic anhydride-induced acute contact hypersensitivity mouse model.
Chai, OH; Fan, YJ; Jeong, HJ; Nguyen, TV; Piao, CH; Song, CH, 2022
)
0.95

Bioavailability

ExcerptReferenceRelevance
" The main findings of the Bayesian study are consistent with our chemistry-based approach and our previously published assessment of the key determinants of sensitization potency, in particular the relatively high predictive value found for chemical reactivity data and the relatively low predictive value for bioavailability parameters."( Integrated testing and assessment approaches for skin sensitization: a commentary.
Patlewicz, GY; Roberts, DW, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Indeed, an inverse dose-response relationship for IFN-gamma expression was exhibited by all three platinum salts, suggestive of the elaboration by platinum salt activated LNC of an inhibitory factor or factors for IFN-gamma."( Selective induction of type 2 cytokines following topical exposure of mice to platinum salts.
Basketter, DA; Dearman, RJ; Kimber, I, 1998
)
0.3
" The sensitizing capacity of known allergens was quantified by dose-response modeling."( A quantitative method for assessing the sensitizing potency of low molecular weight chemicals using a local lymph node assay: employment of a regression method that includes determination of the uncertainty margins.
de Jong, WH; Slob, W; van Loveren, H; van Och, FM; Vandebriel, RJ, 2000
)
0.31
" The dose-response study was designed to determine whether respiratory responses during a single inhalation challenge with TMA (25-30 mg/m3 for 30 min, 3 weeks after the initial induction), the ensuing non-specific airway hyperresponsiveness (AH) to methacholine (MCh) aerosol, and infiltration of eosinophilic granulocytes into the lungs of sensitized Brown Norway (BN) rats are associated and dependent on the concentration of TMA used for topical induction."( Respiratory hypersensitivity to trimellitic anhydride in Brown Norway rats: analysis of dose-response following topical induction and time course following repeated inhalation challenge.
Pauluhn, J, 2003
)
0.6
" Variables investigated included cell concentration, time in culture, dosing regimens (a 13 day and a truncated 8 day protocol) and the impact of restimulation in vitro with T cell mitogens."( Cytokine profiling of chemical allergens in mice: impact of mitogen on selectivity of response.
Betts, CJ; Caddick, HT; Dearman, RJ; Kimber, I, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cyclic dicarboxylic anhydrideAn acid anhydride derived by loss of water between two carboxylic groups in the same molecule so as to close a ring.
dioxo monocarboxylic acidAny monocarboxylic acid containing two ketonic or aldehydic oxo groups.
2-benzofurans
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency19.64610.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency55.85650.000817.505159.3239AID1159531
pregnane X nuclear receptorHomo sapiens (human)Potency47.56560.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency45.35870.000229.305416,493.5996AID743069; AID743079
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency13.90840.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency21.68990.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (213)

TimeframeStudies, This Drug (%)All Drugs %
pre-199048 (22.54)18.7374
1990's72 (33.80)18.2507
2000's59 (27.70)29.6817
2010's28 (13.15)24.3611
2020's6 (2.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.70 (24.57)
Research Supply Index5.46 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index75.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (2.13%)6.00%
Case Studies12 (5.11%)4.05%
Observational0 (0.00%)0.25%
Other218 (92.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]